1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics 2022 - Europe (p2)

Healthcare Analysis & Statistics 2022 - Europe (p2)

31-60 of about 200 reports

Glaucoma  - Epidemiology Forecast to 2030

  • $ 3750
  • May 2021
  • 156 pages

‘Glaucoma—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Glaucoma , historical and forecasted epidemiology as well as the Glaucoma trends in the United States, EU5 ...

  • Japan
  • Spain
  • Ophthalmology
  • Eye Disease
  • Industry analysis

Sepsis - Epidemiology Forecast to 2030

  • $ 3750
  • May 2021
  • 108 pages

‘Sepsis—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Sepsis , historical and forecasted epidemiology as well as the Sepsis trends in the United States, EU5 (Germany, ...

  • United States
  • Spain
  • Blood Disease
  • Industry analysis

Heart Failure - Epidemiology forecast- 2030

  • $ 3750
  • May 2021
  • 80 pages

‘Heart Failure (HF)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the HF, historical and forecasted epidemiology as well as the HF trends in the United States, EU5 (Germany, ...

  • United States
  • Spain
  • Heart Failure
  • Epidemiology
  • Industry analysis

Microscopic Polyangiitis - Epidemiology Forecast to 2030

  • $ 3750
  • May 2021
  • 80 pages

‘Microscopic polyangiitis (MPA) —Epidemiology Forecast–2030’ report delivers an in-depth understanding of the MPA, historical and forecasted epidemiology as well as the MPA epidemiology trends ...

  • Japan
  • Germany
  • Epidemiology
  • Autoimmune Disease
  • Industry analysis
  • Population Size

Age-related Vision Dysfunction - Epidemiology Forecast to 2030

  • $ 5370
  • May 2021
  • 100 pages

‘Age-related Vision Dysfunction - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Age-related Vision Dysfunction epidemiology in the ...

  • United States
  • Japan
  • Epidemiology
  • Ophthalmology
  • Industry analysis
  • Elderly Population

Wet Age-Related Macular Degeneration (Wet-AMD) - Pipeline Insight, 2021

  • $ 2500
  • May 2021
  • 190 pages

“Wet Age-Related Macular Degeneration (Wet-AMD) - Pipeline Insight, 2021,” report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Wet Age-Related Macular Degeneration ...

  • Europe
  • Australia
  • Eye Disease
  • Ophthalmology
  • Industry analysis

T cell lymphoma - Pipeline Insight, 2021

  • $ 2500
  • May 2021
  • 200 pages

“T cell lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in T cell lymphoma pipeline landscape. It covers the pipeline drug profiles, ...

  • United States
  • Europe
  • Lymphoma
  • Industry analysis

Exocrine Pancreatic Insufficiency (EPI) - Epidemiology Forecast–2030

  • $ 3750
  • April 2021
  • 90 pages

Overview ‘Exocrine Pancreatic Insufficiency (EPI) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Exocrine Pancreatic Insufficiency ...

  • Japan
  • Spain
  • Digestive System Disorder
  • Industry analysis

Postpartum Depression - Epidemiology Forecast to 2030

  • $ 3750
  • April 2021
  • 80 pages

‘Postpartum Depression (PPD) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Postpartum Depression (PPD) epidemiology in the United ...

  • United States
  • Spain
  • Epidemiology
  • Industry analysis

Tadekinig Alfa- Emerging Insight and Market Forecast – 2030

  • $ 3250
  • April 2021
  • 35 pages

“Tadekinig Alfa- Emerging Insight and Market Forecast – 2030” report provides comprehensive insights about an investigational product for Hemophagocytic Lymphohistiocytosis (HLH): Primary HLH, Secondary ...

  • United States
  • Japan
  • Research And Development
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Diabetic retinopathy - Epidemiology Forecast to 2030

  • $ 3750
  • April 2021
  • 90 pages

‘Diabetic Retinopathy (DR) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Diabetic Retinopathy, historical and forecasted epidemiology in the United States, EU5 ...

  • United States
  • Germany
  • Type 2 Diabetes
  • Industry analysis
  • Diabetes Prevalence

Surgical Site Infection (SSI) - Epidemiology Forecast to 2030

  • $ 3750
  • April 2021
  • 70 pages

‘Surgical site infection (SSI)–Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Surgical site infection (SSI), historical and forecasted epidemiology in the United States, ...

  • United States
  • Italy
  • Infection Control
  • Industry analysis
  • Surgical Procedures Performed

Granulomatosis with Polyangiitis - Epidemiology Forecast to 2030

  • $ 3750
  • April 2021
  • 60 pages

‘Granulomatosis with polyangiitis (GPA) – Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the historical and forecasted epidemiology of GPA in the United States, EU5 ...

  • Germany
  • United States
  • Epidemiology
  • Industry analysis

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)— Epidemiology Forecast to 2030

  • $ 3750
  • March 2021
  • 75 pages

‘EGFR Inhibitors-Induced Skin Disorders- Epidemiology Forecast–2030’ report delivers an in-depth understanding of the EGFR Inhibitors-Induced Skin Disorders historical and forecasted epidemiology ...

  • United States
  • Spain
  • Epidemiology
  • Industry analysis

Beta thalassemia - Pipeline Insight, 2021

  • $ 2000
  • March 2021
  • 60 pages

“Beta thalassemia - Pipeline Insight, 2021,” report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in Beta thalassemia pipeline landscape. It covers the pipeline drug profiles, ...

  • United States
  • World
  • Blood Disease
  • Industry analysis

Glioblastoma multiforme (GBM) - Epidemiology Forecast to 2030

  • $ 3750
  • February 2021
  • 171 pages

‘Glioblastoma Multiforme (GBM) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Glioblastoma Multiforme (GBM) epidemiology in the ...

  • Spain
  • France
  • Brain Cancer
  • Industry analysis

LY3454738- Emerging Insight and Market Forecast – 2030

  • $ 3250
  • February 2021
  • 35 pages

“LY3454738- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Chronic Spontaneous Urticaria in 7 Major Markets. A detailed ...

  • Japan
  • Spain
  • Research And Development
  • Dermatological Condition
  • Industry analysis
  • Health Expenditure

Aliqopa - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Aliqopa - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Aliqopa ...

  • Europe
  • Japan
  • Lymphoma
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Acalabrutinib- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“ACALABRUTINIB - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

BI 764524 - Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“BI 764524 - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diabetic Retinopathy in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Type 2 Diabetes
  • Research And Development
  • Industry analysis
  • Health Expenditure

ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diffuse large B-cell lymphoma (DLBCL) in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

Blinatumomab- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“BLINATUMOMAB - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B-cell lymphoma (DLBCL) in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Monoclonal Antibody
  • Industry analysis
  • Health Expenditure

DB-102- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“DB-102- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed ...

  • Europe
  • World
  • Lymphoma
  • Research And Development
  • Industry analysis
  • Health Expenditure

RG 7774 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“RG 7774 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diabetic Retinopathy in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Type 2 Diabetes
  • Research And Development
  • Industry analysis
  • Health Expenditure

Loncastuximab tesirine- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“LONCASTUXIMAB TESIRINE- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Therapy
  • Industry analysis
  • Health Expenditure

Treakisym- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“TREAKISYM - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse large B cell lymphoma in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Lymphoma
  • Industry analysis
  • Health Expenditure

Ublituximab + Umbralisib- Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“UBLITUXIMAB + UMBRALISIB - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse Large B-Cell Lymphoma in 7 Major Markets. ...

  • Europe
  • Japan
  • Lymphoma
  • Therapy
  • Industry analysis
  • Health Expenditure

ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“ARIMOCLOMOL - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Gaucher disease in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Research And Development
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Zydelig - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “Zydelig - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Zydelig ...

  • Europe
  • Japan
  • Immunotherapy
  • Lymphoma
  • Industry analysis
  • Health Expenditure

PR001 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“PR001 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Gaucher disease in 7 Major Markets. A detailed picture of the PR001 ...

  • Europe
  • Japan
  • Research And Development
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on